Cochrane Abstracts
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma Edited (no change to conclusions)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Addition of Long‐acting Beta2‐agonists (LABA) for Adults With Asthma Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma_Edited__no_change_to_conclusions_. Accessed 03 June 2023.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma_Edited__no_change_to_conclusions_. Accessed June 3, 2023.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma_Edited__no_change_to_conclusions_
Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Addition of Long‐acting Beta2‐agonists (LABA) for Adults With Asthma Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2023 June 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma Edited (no change to conclusions)
ID - 432748
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432748/all/Long‐acting_muscarinic_antagonists__LAMA__added_to_inhaled_corticosteroids__ICS__versus_addition_of_long‐acting_beta2‐agonists__LABA__for_adults_with_asthma_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
